Science Insider reports that DeCode Genetics only has enough cash to make it to the summer. The company lost millions of dollars when Lehman Brothers, which managed its finances, went bankrupt, though it was later able to sell some of those securities. Even as CEO Kári Stefánsson says DeCode is in "a very tough spot," the company is optimistic as it restructures its debt and re-emphasizes its diagnostic tests.
Eh, Everybody's Broke These Days
Apr 01, 2009